Latest filing published 01 Sept 2026 for Thermo Fisher Scientific INC., €387k.
First 200 filings with a declared amount
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Marc N. Casper has 1,082 filings, published from February 17, 2016 to September 1, 2026, 1,076 of them at Thermo Fisher Scientific Inc. (title Chairman & CEO) and 6 at Synopsys Inc, where Casper is a Director. The 850 sales come to EUR 640,202,457 in total, with a median of EUR 416,695 per sale. The largest: EUR 26,833,121 on October 1, 2018, EUR 7,923,134 on November 15, 2017 and EUR 7,024,954 on July 28, 2020.
The record's 2 purchases, EUR 270,631 and EUR 135,646, are at Synopsys Inc on the same day, March 25, 2024. The record also holds 98 option exercises, 91 share grants and 41 filings of another kind.
The yearly volume jumps from 2022: 227 filings in 2022, 175 in 2023, 237 in 2024, 78 in 2025 and 133 in 2026, against 21 to 70 a year before. Over the last twelve months, 151 filings, 134 of them sales. Median publication delay: 2 days, across 1,080 dated filings.
At Thermo Fisher Scientific Inc., Gianluca Pettiti has 232 trades within 30 days of Casper's, Michael A. Boxer 189, Lisa P. Britt 172, Joseph R. Holmes 167 and Stephen Williamson 155, all in the same direction.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 1082 declarations